October 01, 2025

How Safe Are FDA-Cleared AI Tools?

“These findings indicate that standardized efficacy, safety, and risk assessment reporting remains inadequate for FDA-cleared AI/ML devices, underscoring the need for dedicated regulatory pathways and robust postmarket surveillance to ensure patient safety."

Conexiant

September 29, 2025

Clinicians: Ultraprocessed Food Limits Coming to Cafeterias?

States consider bipartisan bans on ultraprocessed foods in schools over obesity and child health.

KFF Health News

September 29, 2025

ACC Calls for Universal Inflammation Screening

New scientific statement positions hsCRP testing alongside cholesterol as evidence mounts for targeting residual inflammatory risk. 

Conexiant

September 29, 2025

Meta-Analysis Finds Higher Cardiovascular Risk in IPF

Cardiovascular disease occurs more often in patients with idiopathic pulmonary fibrosis.

Conexiant

September 29, 2025

Levodopa Investigated for Stroke Rehabilitation: ESTREL Trial

Swiss trial across 13 stroke units and 11 rehab centers challenges levodopa use in stroke recovery.

Conexiant

September 25, 2025

CT-Detected Emphysema Predicted COPD Mortality

Severe emphysema increased COPD death risk more than 12-fold in lung screening cohort.

Conexiant

September 25, 2025

GLP-1 RAs Show Lower Risks in Psoriasis

GLP-1 RAs use in psoriasis is associated with lower alcohol and substance abuse risks.

Conexiant

September 24, 2025

Surgery Versus GLP-1: Long-Term Diabetes Outcomes

Metabolic surgery associated with lower mortality and retinopathy risk versus glucagon-like peptide-1 therapy in diabetes and obesity.

Conexiant

September 23, 2025

AI Model Predicts Multiple Disease Risk

Delphi-2M transformer, trained on nearly 2 million patients, predicts disease progression and mortality risk years in advance

Conexiant